Position
President
Company
Intra-Cellular Therapies
New YorkBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Intra-Cellular Therapies promotes Michael Halstead, J.D. to the position of President, where he will oversee several key functions within the company. The company also announces the retirement of Senior Vice President and Chief Financial Officer, Larry Hineline.
Quick answer
Intra-Cellular Therapies Promotes Michael Halstead to President (March 19, 2024). Intra-Cellular Therapies is based in New York, New York, United States.
- Who is the new President at Intra-Cellular Therapies?
- Intra-Cellular Therapies named Michael Halstead President, announced March 19, 2024.
- What did Intra-Cellular Therapies announce on March 19, 2024?
- Intra-Cellular Therapies promotes Michael Halstead, J.D. to the position of President, where he will oversee several key functions within the company. The company also announces the retirement of Senior Vice President and Chief Financial Officer, Larry Hineline.
- What does Intra-Cellular Therapies do?
- Intra-Cellular Therapies is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders.
- Where is Intra-Cellular Therapies based?
- Intra-Cellular Therapies is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- BioNTech (March 20, 2024), Fulcrum Therapeutics (March 18, 2024), Oragenics (March 18, 2024) and AVEO Pharmaceuticals (March 25, 2024) also announced leadership changes within 45 days of Intra-Cellular Therapies.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BioNTech Appoints Annemarie Hanekamp as Chief Commercial Officer (March 20, 2024)
- Fulcrum Appoints Patrick Horn, M.D., Ph.D., as Chief Medical Officer (March 18, 2024)
- Oragenics Appoints Dr. James Kelly as Chief Medical Officer (March 18, 2024)
- AVEO Oncology Appoints Edgar E. Braendle as Chief Medical Officer (March 25, 2024)
- Madrigal Pharmaceuticals Appoints Mardi C. Dier as Senior Vice President and Chief Financial Officer (March 11, 2024)
- Nuvation Bio Appoints Colleen Sjogren as Chief Commercial Officer (March 28, 2024)
Who to call at Intra-Cellular Therapies, and when
A new leader at Intra-Cellular Therapies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Intra-Cellular Therapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Intra-Cellular Therapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Intra-Cellular Therapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Intra-Cellular Therapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Intra-Cellular Therapies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.